FyMed, Inc.

Press Releases
drug discovery

FyMed Announces Notice of Allowance for US Patent Covering Fy10 Technology Platform

FyMed Inc., a specialty pharmaceutical company focused on the development and commercialization of novel therapeutics announced that its application covering the Fy10 technology platform was allowed for issuance as a new patent by the USPTO. Read More...

Early Release: FyMed Gets Patent for Novel Immunomodulatory Drug

Pharmaceutical firm FyMed Inc. has received a patent for a novel immunomodulatory drug used in the treatment of autoimmune diseases.

FyMed Reinforces Its Drug Development Pipeline With Novel Strategies in Precision Medicine

FyMed, Inc., a pharmaceutical company utilizing proprietary methodologies in evidence-based medicine for drug discoveries recently announced plans for the strategic and operational reinforcements of their drug development pipeline through innovative approaches in precision medicine. Read More...